Dry Eye Syndrome
Showing NaN - NaN of 5
Dry Eye Syndrome Trial in United States (rhNGF 20 µg/ml, rhNGF 20 µg/ml + vehicle, Vehicle)
Completed
- Dry Eye Syndrome
- rhNGF 20 μg/ml
- +2 more
-
Glendale, California
- +11 more
Jan 13, 2022
Dry Eye Syndrome Trial in United States (Low Dose - SkQ1, High dose - SkQ1, SkQ1 (Vehicle))
Completed
- Dry Eye Syndrome
- Low Dose - SkQ1
- +2 more
-
Phoenix, Arizona
- +6 more
Dec 20, 2021
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
-
Newport Beach, California
- +8 more
Dec 8, 2021
Dry Eye Syndrome Trial in United States (BRM421, Placebo)
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in Artesia, Newport Beach (Oculeve Intranasal Neurostimulator)
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- Oculeve Intranasal Neurostimulator
-
Artesia, California
- +1 more
Sep 27, 2017